These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38322778)
1. Use of rectal balloon spacer in patients with localized prostate cancer receiving external beam radiotherapy. Costa P; Vale J; Fonseca G; Costa A; Kos M Tech Innov Patient Support Radiat Oncol; 2024 Mar; 29():100237. PubMed ID: 38322778 [TBL] [Abstract][Full Text] [Related]
2. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
4. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103. Taggar AS; Charas T; Cohen GN; Boonyawan K; Kollmeier M; McBride S; Mathur N; Damato AL; Zelefsky MJ Brachytherapy; 2018; 17(2):251-258. PubMed ID: 29241706 [TBL] [Abstract][Full Text] [Related]
5. Polyethylene glycol hydrogel rectal spacer implantation in patients with prostate cancer undergoing combination high-dose-rate brachytherapy and external beam radiotherapy. Yeh J; Lehrich B; Tran C; Mesa A; Baghdassarian R; Yoshida J; Torrey R; Gazzaniga M; Weinberg A; Chalfin S; Ravera J; Tokita K Brachytherapy; 2016; 15(3):283-287. PubMed ID: 26853354 [TBL] [Abstract][Full Text] [Related]
6. Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial. See AW; Bowden P; Wells G; Appu S; Lawrentschuk N; Liodakis P; Pandeli C; Aarons Y; Smyth LML; McKenzie DP Radiat Oncol; 2022 Jul; 17(1):131. PubMed ID: 35879722 [TBL] [Abstract][Full Text] [Related]
7. Use of a Biodegradable, Contrast-Filled Rectal Spacer Balloon in Intensity-Modulated Radiotherapy for Intermediate-Risk Prostate Cancer Patients: Dosimetric Gains in the BioPro-RCMI-1505 Study. Latorzeff I; Bruguière E; Bogart E; Le Deley MC; Lartigau E; Marre D; Pasquier D Front Oncol; 2021; 11():701998. PubMed ID: 34513681 [TBL] [Abstract][Full Text] [Related]
8. Rectum-spacer related acute toxicity - endoscopy results of 403 prostate cancer patients after implantation of gel or balloon spacers. Schörghofer A; Drerup M; Kunit T; Lusuardi L; Holzinger J; Karner J; Groher M; Zoubek C; Forstner R; Sedlmayer F; Wolf F Radiat Oncol; 2019 Mar; 14(1):47. PubMed ID: 30876433 [TBL] [Abstract][Full Text] [Related]
9. SpaceOAR hydrogel spacer injection prior to stereotactic body radiation therapy for men with localized prostate cancer: A systematic review. Payne HA; Pinkawa M; Peedell C; Bhattacharyya SK; Woodward E; Miller LE Medicine (Baltimore); 2021 Dec; 100(49):e28111. PubMed ID: 34889268 [TBL] [Abstract][Full Text] [Related]
10. Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared to Rectal Balloon Immobilization After Proton Beam Radiation Therapy for Localized Prostate Cancer: A Retrospective Observational Study. Dinh TT; Lee HJ; Macomber MW; Apisarnthanarax S; Zeng J; Laramore GE; Rengan R; Russell KJ; Chen JJ; Ellis WJ; Schade GR; Liao JJ Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):635-643. PubMed ID: 32035187 [TBL] [Abstract][Full Text] [Related]
11. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer. Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008 [TBL] [Abstract][Full Text] [Related]
12. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. Mohammed N; Kestin L; Ghilezan M; Krauss D; Vicini F; Brabbins D; Gustafson G; Ye H; Martinez A Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):204-12. PubMed ID: 21167653 [TBL] [Abstract][Full Text] [Related]
13. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839 [TBL] [Abstract][Full Text] [Related]
14. The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device? Teh BS; McGary JE; Dong L; Mai WY; Carpenter LS; Lu HH; Chiu JK; Woo SY; Grant WH; Butler EB Cancer J; 2002; 8(6):476-83. PubMed ID: 12500857 [TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study. Björeland U; Notstam K; Fransson P; Söderkvist K; Beckman L; Jonsson J; Nyholm T; Widmark A; Thellenberg Karlsson C Radiat Oncol; 2023 Jan; 18(1):1. PubMed ID: 36593460 [TBL] [Abstract][Full Text] [Related]
16. The use of hydrogel spacer in men undergoing high-dose prostate cancer radiotherapy: results of a prospective phase 2 clinical trial. Chao M; Lim Joon D; Khoo V; Lawrentschuk N; Ho H; Spencer S; Chan Y; Tan A; Pham T; Sengupta S; McMillan K; Liu M; Koufogiannis G; Cham CW; Foroudi F; Bolton D World J Urol; 2019 Jun; 37(6):1111-1116. PubMed ID: 30251049 [TBL] [Abstract][Full Text] [Related]
17. Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials. Jones RT; Hassan Rezaeian N; Desai NB; Lotan Y; Jia X; Hannan R; Kim DWN; Hornberger B; Dubas J; Laine AM; Zelefsky MJ; Timmerman RD; Folkert MR Med Dosim; 2017 Winter; 42(4):341-347. PubMed ID: 28774760 [TBL] [Abstract][Full Text] [Related]
18. Prospective analysis of hydrogel spacer for patients with prostate cancer undergoing radiotherapy. Chao M; Ho H; Chan Y; Tan A; Pham T; Bolton D; Troy A; Temelcos C; Sengupta S; McMillan K; Cham CW; Liu M; Ding W; Subramanian B; Wasiak J; Lim Joon D; Spencer S; Lawrentschuk N BJU Int; 2018 Sep; 122(3):427-433. PubMed ID: 29520983 [TBL] [Abstract][Full Text] [Related]
19. Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? A Dosimetric and Radiobiological Comparison Study. Ahmad Khalil D; Wulff J; Jazmati D; Geismar D; Bäumer C; Kramer PH; Steinmeier T; Schleithoff SS; Tschirdewahn S; Hadaschik B; Timmermann B Curr Oncol; 2023 Jan; 30(1):758-768. PubMed ID: 36661707 [TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Teh BS; Mai WY; Uhl BM; Augspurger ME; Grant WH; Lu HH; Woo SY; Carpenter LS; Chiu JK; Butler EB Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):705-12. PubMed ID: 11172952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]